2026 Abstract Submission

Abstract Submission Information

Abstract Submission Portal: Closed

Late-Breaking Abstract Portal: Open

Abstract submissions for consideration for oral presentation are currently under review for the 2026 MPS World Summit. Late-breaking abstracts can be submitted, but will only be considered for poster display.


Microphysiological System (MPS): cell culture systems replicating (patho-) physiology through engineered organ architecture and functionality. This includes especially 3D-(co-)cultures such as organoids, organ-on-chip models, and multi-organ models, as well as the technologies to engineer and analyze these systems.

Abstracts are invited on the topic of new developments in MPS and applications of MPS, which are divided into four themes.

  • Theme 1: Engineering the Next Generation of MPS
  • Theme 2: Modeling Human Biology with MPS
  • Theme 3: MPS in Product Development
  • Theme 4: Standards, Regulatory Pathways, and Global Adoption


Top-scored abstracts, submitted prior to January 20, may be selected for an oral presentation at one of the scientific sessions.


Abstract Submission Guidelines

  • All abstracts will be evaluated and selected for oral or poster presentation by the MPS Scientific Advisory Committee and the 2026 Program Committee
  • Abstracts must be in English and no more than 350 words (references included; title, authors excluded)
  • Figures, tables, and attachments are not permitted
  • Make sure to select your preferred theme and session
  • Only one abstract is allowed for one presenting author
  • All presenters must be registered for the conference, if accepted


More Details on Abstract Formatting

  • Provide title in normal font (not CAPITALIZED, without initial capitalization)
  • Your abstract submission must contain complete information including:
      1. Background
      2. Objectives
      3. Methods
      4. Results
      5. Conclusions
  • DO NOT use headers for sections in the body of your abstract; if you add headers, they will be removed
  • Provide full first and last names of all authors; abbreviate middle names (e.g., Peter R. S. Parker)
  • Provide affiliations for each author. 
  • Include no more than three references and cite them in the text [1], [2]. 
    Format references as follows:
    Authors (Year). Publication name Volume, Pages. doi: 
    Borotkanics, R. Trush, M. and Locke P. (2015). Appl In Vitro Toxicol 1, 262-275. doi:10.1089/aivt.2014.0006
    e.g. (4 or more authors) Kasai, T., Umeda, Y., Ohnishi, M et al. (2015). Nanotoxicology 9, 413-422. doi:10.3106/17435390.2014.933903
  • Acknowledgements, disclaimers or funding information may be included at the end of the abstract after a line break.


Abstracts will be judged on the following criteria:

  • Objective: How clear is the objective and/or problem statement of this abstract?
  • Methods: How well described is the methods section of this abstract?
  • Results: How well described/accurate are the results section of this abstract?
  • Conclusion: How valid/supported is the discussion or conclusion section of this abstract?
  • Scientific Interest: What is the general scientific interest of this abstract’s subject?
  • Originality: What is the overall originality of this abstract?


Address your questions to: [email protected]

Submit an Abstract